Dale Kim

6PUBLICATIONS
36CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 13, 2026
Impact of Beers Criteria Medications in Elderly Patients With Head and Neck Cancer.

|Sep 18, 2025
Predicting Rejection Risk in Heart Transplantation: An Integrated Clinical-Histopathologic Framework for Personalized Post-Transplant Care.

Dale D Kim, Anant Madabhushi, Kenneth B Margulies

|Mar 27, 2025
Understanding Reasons for Oral Anticoagulation Nonprescription in Atrial Fibrillation Using Large Language Models.

Sulaiman Somani, Dale Daniel Kim, Eduardo Perez-Guerrero

|Feb 28, 2024
Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell-Mediated Cytotoxicity.

Zachary L Z Hay, Dale D Kim, Jennifer M Cimons

|Nov 05, 2023
c-Myc uses Cul4b to preserve genome integrity and promote antiviral CD8+ T cell immunity.

Asif A Dar, Dale D Kim, Scott M Gordon

|May 19, 2022
The ubiquitin ligase Cul5 regulates CD4+ T cell fate choice and allergic inflammation.

Binod Kumar, Natania S Field, Dale D Kim

Pageof 1

Frequent Collaborators

1 joint publications

Aishwarya Suresh

1 joint publications

Christopher F Pastore

1 joint publications

De'Broski R Herbert

1 joint publications

Paula M Oliver